Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB. Teh BS, et al. Among authors: ayala g. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9. doi: 10.1016/j.ijrobp.2003.09.083. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050332 Clinical Trial.
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer.
Teh BS, Aguilar-Cordova E, Vlachaki MT, Aguilar L, Mai WY, Caillouet J, Davis M, Miles B, Kadmon D, Ayala G, Lu HH, Chiu JK, Carpenter LS, Woo SY, Grant WH 3rd, Wheeler T, Thompson TC, Butler EB. Teh BS, et al. Among authors: ayala g. Oncologist. 2002;7(5):458-66. doi: 10.1634/theoncologist.7-5-458. Oncologist. 2002. PMID: 12401909 Free article. Clinical Trial.
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Satoh T, Teh BS, Timme TL, Mai WY, Gdor Y, Kusaka N, Fujita T, Pramudji CK, Vlachaki MT, Ayala G, Wheeler T, Amato R, Miles BJ, Kadmon D, Butler EB, Thompson TC. Satoh T, et al. Among authors: ayala g. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):562-71. doi: 10.1016/j.ijrobp.2004.01.020. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145177 Clinical Trial.
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Tetzlaff MT, et al. Among authors: ayala g. Technol Cancer Res Treat. 2006 Feb;5(1):23-36. doi: 10.1177/153303460600500104. Technol Cancer Res Treat. 2006. PMID: 16417399 Free article. Review.
Cytopathic effect of in situ gene therapy in prostate cancer.
Ayala G, Wheeler TM, Shalev M, Thompson TC, Miles B, Aguilar-Cordova E, Chakraborty S, Kadmon D. Ayala G, et al. Hum Pathol. 2000 Jul;31(7):866-70. doi: 10.1053/hupa.2000.8453. Hum Pathol. 2000. PMID: 10923926
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.
Teh BS, Aguilar-Cordova E, Kernen K, Chou CC, Shalev M, Vlachaki MT, Miles B, Kadmon D, Mai WY, Caillouet J, Davis M, Ayala G, Wheeler T, Brady J, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Butler EB. Teh BS, et al. Among authors: ayala g. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):605-13. doi: 10.1016/s0360-3016(01)01692-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11597799 Clinical Trial.
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.
Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, Yang G, Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, Wheeler TM, Butler EB, Kadmon D, Thompson TC. Miles BJ, et al. Among authors: ayala g. Hum Gene Ther. 2001 Nov 1;12(16):1955-67. doi: 10.1089/104303401753204535. Hum Gene Ther. 2001. PMID: 11686937 Clinical Trial.
637 results